ABOUT

Hound Labs combines science and technology in novel ways to improve health and wellness. The Company believes its ultra-sensitive and portable technologies will pave the way to practical and fair solutions for some of the leading public health and safety issues. In 2022, Hound Labs will launch its first ultra-sensitive point-of-care solution – the HOUND® CANNABIS BREATHALYZER, which allows employers and law enforcement to identify recent cannabis use rapidly and accurately by testing breath on-site. Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist​, founded Hound Labs in 2014.